Conference
305 A high dose of inhaled budesonide is more cost-effective than a low dose in moderate asthma
Authors
Andersson F; Borg S; Barnes PJ; Lödfdahl C-G; O'Byrne P; Postma D; Pauwels RA; Tattersfield A; Ullman A
Volume
105
Pagination
pp. s102-s103
Publisher
Elsevier
Publication Date
January 1, 2000
DOI
10.1016/s0091-6749(00)90734-6
Conference proceedings
The Journal of Allergy and Clinical Immunology
Issue
1
ISSN
0091-6749